Please enable JavaScript and reload the page. Check your browser before going to www.thelancet.com.

  1. Vaccination against COVID-19 for children aged 5 to 11 The Lancet
  2. Effectiveness of the BNT162b2 vaccine against Omicron in children aged 5 to 11 years NEJM nejm.org
  3. The pediatric COVID vaccine is only 51% effective at Omicron, according to the Ynetnews study
  4. Efficacy of Pfizer-BioNTech BNT162b2 vaccine against Delta and Omicron SARS-CoV-2 variants among adolescents News-Medical.Net
  5. Vax’s “moderate” protection against Omicron for Medpage toddlers today
  6. See full coverage on Google News

Leave a Comment

Your email address will not be published. Required fields are marked *